DHTRF
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Market Cap & Net Worth: DHTRF (DHTRF)
DHTRF (PINK:DHTRF) has a market capitalization of $447.38 Million ($447.38 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41602 globally and #13529 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DHTRF's stock price $8.12 by its total outstanding shares 55096476 (55.10 Million).
DHTRF Market Cap History: 2023 to 2025
DHTRF's market capitalization history from 2023 to 2025. Data shows growth from $483.97 Million to $447.38 Million (0.00% CAGR).
DHTRF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DHTRF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.45x
DHTRF's market cap is 3.45 times its annual revenue
1.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $483.97 Million | $93.76 Million | $91.50 Million | 5.16x | 5.29x |
| 2024 | $482.09 Million | $139.68 Million | -$3.36 Million | 3.45x | N/A |
Competitor Companies of DHTRF by Market Capitalization
Companies near DHTRF in the global market cap rankings as of March 19, 2026.
Key companies related to DHTRF by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
DHTRF Historical Marketcap From 2023 to 2025
Between 2023 and today, DHTRF's market cap moved from $483.97 Million to $ 447.38 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $447.38 Million | -7.20% |
| 2024 | $482.09 Million | -0.39% |
| 2023 | $483.97 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of DHTRF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $447.38 Million USD |
| MoneyControl | $447.38 Million USD |
| MarketWatch | $447.38 Million USD |
| marketcap.company | $447.38 Million USD |
| Reuters | $447.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.